SK179399A3 - Use of insulin sensitiser and an insulin - Google Patents

Use of insulin sensitiser and an insulin Download PDF

Info

Publication number
SK179399A3
SK179399A3 SK1793-99A SK179399A SK179399A3 SK 179399 A3 SK179399 A3 SK 179399A3 SK 179399 A SK179399 A SK 179399A SK 179399 A3 SK179399 A3 SK 179399A3
Authority
SK
Slovakia
Prior art keywords
compound
insulin
diabetes mellitus
comprises administering
administration
Prior art date
Application number
SK1793-99A
Other languages
English (en)
Slovak (sk)
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK179399A3 publication Critical patent/SK179399A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SK1793-99A 1997-06-18 1998-06-15 Use of insulin sensitiser and an insulin SK179399A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712866.4A GB9712866D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
PCT/EP1998/003692 WO1998057636A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with rosiglitazone and insulin

Publications (1)

Publication Number Publication Date
SK179399A3 true SK179399A3 (en) 2000-11-07

Family

ID=10814527

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1793-99A SK179399A3 (en) 1997-06-18 1998-06-15 Use of insulin sensitiser and an insulin

Country Status (30)

Country Link
EP (1) EP0999837A1 (el)
JP (1) JP2002504138A (el)
KR (1) KR20010013843A (el)
CN (1) CN1133431C (el)
AP (1) AP1287A (el)
AR (2) AR012997A1 (el)
AU (1) AU8216398A (el)
BG (1) BG104059A (el)
BR (1) BR9810444A (el)
CA (1) CA2294141A1 (el)
CO (1) CO4940454A1 (el)
DZ (1) DZ2521A1 (el)
EA (1) EA004800B1 (el)
GB (1) GB9712866D0 (el)
HU (1) HUP0003260A3 (el)
ID (1) ID23951A (el)
IL (1) IL133143A0 (el)
IN (1) IN189723B (el)
MA (1) MA26511A1 (el)
NO (1) NO996265L (el)
OA (1) OA11517A (el)
PE (1) PE104499A1 (el)
PL (1) PL343123A1 (el)
SK (1) SK179399A3 (el)
TR (1) TR199903095T2 (el)
TW (1) TW587937B (el)
UA (1) UA70299C2 (el)
UY (1) UY25050A1 (el)
WO (1) WO1998057636A1 (el)
ZA (1) ZA985237B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) * 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
PT1173434E (pt) 1999-04-23 2003-12-31 Smithkline Beecham Plc Novo produto farmaceutico
WO2000078333A2 (en) * 1999-06-21 2000-12-28 Eli Lilly And Company Synergetic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependant diabetes
WO2001000223A2 (en) 1999-06-25 2001-01-04 Minimed Inc. Multiple agent diabetes therapy
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
US6852694B2 (en) 2001-02-21 2005-02-08 Medtronic Minimed, Inc. Stabilized insulin formulations
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes
US20020198203A1 (en) * 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and a thiazolidinedione agent
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
MXPA05004743A (es) 2002-11-08 2005-08-03 Hoffmann La Roche Derivados 4-alcoxioxazol sustituidos como agonistas ppar.
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102389427A (zh) * 2011-10-10 2012-03-28 成都恒瑞制药有限公司 含有罗格列酮和盐酸西替利嗪的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376829T1 (de) * 1993-09-15 2007-11-15 Daiichi Sankyo Co Ltd Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm)
JPH11510508A (ja) * 1995-08-10 1999-09-14 ワーナー−ランバート・コンパニー インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法
AU725998B2 (en) * 1995-09-18 2000-10-26 Eisai R&D Management Co., Ltd. Treating NIDDM with RXR agonists

Also Published As

Publication number Publication date
IN189723B (el) 2003-04-19
NO996265D0 (no) 1999-12-17
AR012997A1 (es) 2000-11-22
UY25050A1 (es) 2000-09-29
CO4940454A1 (es) 2000-07-24
ZA985237B (en) 2000-02-17
IL133143A0 (en) 2001-03-19
MA26511A1 (fr) 2004-12-20
EA004800B1 (ru) 2004-08-26
BR9810444A (pt) 2000-09-05
AP9901718A0 (en) 1999-12-31
CN1133431C (zh) 2004-01-07
NO996265L (no) 1999-12-17
TR199903095T2 (xx) 2000-08-21
HUP0003260A2 (hu) 2001-05-28
EP0999837A1 (en) 2000-05-17
BG104059A (en) 2000-10-31
ID23951A (id) 2000-06-08
GB9712866D0 (en) 1997-08-20
AR015894A1 (es) 2001-05-30
CA2294141A1 (en) 1998-12-23
AU8216398A (en) 1999-01-04
DZ2521A1 (fr) 2003-02-08
OA11517A (en) 2004-02-04
PL343123A1 (en) 2001-07-30
WO1998057636A1 (en) 1998-12-23
HUP0003260A3 (en) 2001-12-28
TW587937B (en) 2004-05-21
CN1260715A (zh) 2000-07-19
KR20010013843A (ko) 2001-02-26
PE104499A1 (es) 2000-01-13
JP2002504138A (ja) 2002-02-05
UA70299C2 (en) 2004-10-15
EA200000042A1 (ru) 2000-08-28
AP1287A (en) 2004-06-26

Similar Documents

Publication Publication Date Title
SK286029B6 (sk) Farmaceutický prostriedok a jeho použitie
EP1292300B1 (en) Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus
SK179399A3 (en) Use of insulin sensitiser and an insulin
SK285484B6 (sk) Kombinácia obsahujúca 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, inzulínový sekrečný promótor a biguanidovú antihyperglykémickú látku, farmaceutický prostriedok s jej obsahom a ich použitie na liečbu diabetu
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
CA2292629C (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
US20030187030A1 (en) Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
EP0999845B1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
SK612000A3 (en) Application of insulin sensitiser, insulin secretagogue and alpha glucosidase inhibitor antihyperglycaemic agent for the treatment of diabetes mellitus and conditions associated with diabetes mellitus and a pharmaceutical composition
SK179499A3 (en) The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
US20040106543A1 (en) Treatment of diabetes with rosiglitazone and insulin
AU783539B2 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
AU778947B2 (en) Treatment of diabetes with thiazolidinedione and metformin
MXPA99012065A (en) Treatment of diabetes with rosiglitazone and insulin
NZ518076A (en) 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (BRL49653) for treating non-insulin dependent diabetes (NIDDM)
AU1552102A (en) Treatment of diabetes with rosiglitazone and insulin
CZ9904579A3 (cs) Léčivo pro léčbu diabetes mellitus a stavů spojených s diabetes mellitus